Regeneron CEO says Covid antibody cocktail may be less effective against omicron variant
November 30, 2021 at 10:08 AM EST
Regeneron Pharmaceuticals' Covid-19 antibody cocktail, and similar drugs, could be less effective against the omicron coronavirus variant, the company said.